Dolby Laboratories $DLB Shares Acquired by Illinois Municipal Retirement Fund

by · The Markets Daily

Illinois Municipal Retirement Fund raised its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 38.0% during the 3rd quarter, Holdings Channel reports. The firm owned 71,215 shares of the electronics maker’s stock after buying an additional 19,607 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Dolby Laboratories were worth $4,185,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Bank of New York Mellon Corp acquired a new stake in Dolby Laboratories in the 2nd quarter valued at $253,289,000. First Trust Advisors LP raised its position in Dolby Laboratories by 19.9% during the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock worth $135,431,000 after acquiring an additional 374,405 shares during the period. Allspring Global Investments Holdings LLC acquired a new position in Dolby Laboratories during the third quarter worth $13,622,000. Arrowstreet Capital Limited Partnership lifted its holdings in Dolby Laboratories by 507.5% during the first quarter. Arrowstreet Capital Limited Partnership now owns 124,509 shares of the electronics maker’s stock valued at $7,478,000 after purchasing an additional 104,014 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in Dolby Laboratories by 6.8% during the first quarter. Dimensional Fund Advisors LP now owns 1,321,407 shares of the electronics maker’s stock valued at $79,357,000 after purchasing an additional 83,835 shares in the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CAO Ryan Nicholson sold 1,183 shares of the stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total value of $77,226.24. Following the completion of the sale, the chief accounting officer owned 34,453 shares of the company’s stock, valued at $2,249,091.84. This represents a 3.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP John Couling sold 7,667 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total transaction of $450,666.26. Following the sale, the senior vice president owned 166,803 shares of the company’s stock, valued at $9,804,680.34. This represents a 4.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,517 shares of company stock worth $995,963 over the last quarter. 37.93% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on DLB shares. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Weiss Ratings raised shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Zacks Research cut Dolby Laboratories from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 28th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $87.50.

View Our Latest Stock Analysis on DLB

Dolby Laboratories Trading Up 0.0%

Shares of DLB opened at $63.62 on Monday. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $69.95. The firm has a market capitalization of $5.96 billion, a P/E ratio of 27.07 and a beta of 0.78. The firm has a 50-day moving average price of $60.99 and a 200 day moving average price of $59.43.

Dolby Laboratories declared that its Board of Directors has approved a stock buyback plan on Thursday, July 30th that allows the company to buy back $350 million in outstanding shares. This repurchase authorization allows the electronics maker to buy up to 7% of its stock through open market purchases. Share repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

See Also

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).